Cellular and molecular mechanisms of apoptosis in age-related muscle atrophy

Current Aging Science

Volumn 4, Issue 3, 2011, Pages 269-278

  Dirks Naylor, Amie J ^a   Lennon Edwards, Shannon ^b  

^a WINGATE UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Aging; Mitochondria; p53; Sarcopenia; Skeletal muscle; Tumor necrosis factor alpha

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CASPASE 10; CASPASE 12; CASPASE 8; CASPASE 9; CELL RECEPTOR; CYSTEINE PROTEINASE; CYTOCHROME C; ENDONUCLEASE G; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; AEROBIC CAPACITY; AGING; APOPTOSIS; CATABOLISM; CELL CYCLE; CELL DEATH; CELL SURVIVAL; DIMERIZATION; DNA FRAGMENTATION; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LACTIC ACIDEMIA; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE CELL; MYOTUBE; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; HUMANS; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 82955246250     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 1995; 50 (Spec No): 11-6.
2. Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 2003; 58 (10): M911-6.
3. Leeuwenburgh C, Wagner P, Holloszy JO, Sohal RS, Heinecke JW. Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch Biochem Biophys 1997; 346 (1): 74-80.
4. Faulkner JA, Brooks SV, Zerba E. Muscle atrophy and weakness with aging: contraction-induced injury as an underlying mechanism. J Gerontol A Biol Sci Med Sci 1995; 50 (Spec No): 124-9.
5. Bua EA, McKiernan SH, Wanagat J, McKenzie D, Aiken JM. Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia. J Appl Physiol 2002; 92 (6): 2617-24.
6. Baker DJ, Hepple RT. Elevated caspase and AIF gene expression correlate with progression of sarcopenia during aging in male F344BN rats. Exp Gerontol 2006; 41 (11): 1149-56.
7. Chung L, Ng YC. Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle. Biochim Biophys Acta 2006; 1762: 103-9.
8. Dirks A, Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am J Physiol Regul Integr Comp Physiol 2002; 282 (2): R519-27.
9. Dirks AJ, Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12. Free Radic Biol Med 2004; 36 (1): 27-39.
10. Rice KM, Blough ER. Sarcopenia-related apoptosis is regulated differently in fast-and slow-twitch muscles of the aging F344/N x BN rat model. Mech Ageing Dev 2006; 127 (8): 670-9.
11. Pistilli EE, Jackson JR, Alway SE. Death receptor-associated proapoptotic signaling in aged skeletal muscle. Apoptosis 2006; 11 (12): 2115-26.
12. Pistilli EE, Siu PM, Alway SE. Molecular regulation of apoptosis in fast plantaris muscles of aged rats. J Gerontol A Biol Sci Med Sci 2006; 61 (3): 245-55.
13. Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-{alpha} signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J 2005; 19 (6): 668-70.
14. Song W, Kwak HB, Lawler JM. Exercise training attenuates ageinduced changes in apoptotic signaling in rat skeletal muscle. Antioxid Redox Signal 2006; 8 (3-4): 517-28.
15. Leeuwenburgh C, Gurley CM, Strotman BA, Dupont-Versteegden EE. Age-related differences in apoptosis with disuse atrophy in soleus muscle. Am J Physiol Regul Integr Comp Physiol 2005; 288 (5): R1288-96.
16. Siu PM, Pistilli EE, Alway SE. Apoptotic responses to hindlimb suspension in gastrocnemius muscles from young adult and aged rats. Am J Physiol Regul Integr Comp Physiol 2005; 289 (4): R1015-26.
17. Tamilselvan J, Jayaraman G, Sivarajan K, Panneerselvam C. Agedependent upregulation of p53 and cytochrome c release and susceptibility to apoptosis in skeletal muscle fiber of aged rats: Role of carnitine and lipoic acid. Free Radic Biol Med 2007; 43 (12): 1656-69.
18. Ogata T, Machida S, Oishi Y, Higuchi M, Muraoka I. Differential cell death regulation between adult-unloaded and aged rat soleus muscle. Mech Ageing Dev 2009; 130 (5): 328-36.
19. Marzetti E, Carter CS, Wohlgemuth SE, Lees HA, Giovannini S, Anderson B, Quinn LS, Leeuwenburgh C. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev 2009; 130 (4): 272-80.
20. Pike CJ. Estrogen modulates neuronal Bcl-xL expression and betaamyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 1999; 72 (4): 1552-63.
21. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1 (2): 120-9.
22. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82 (11): 1111-29.
23. Bennett MR, Macdonald K, Chan SW, Boyle JJ, Weissberg PL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res 1998; 82 (6): 704-12.
24. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002; 1585 (2-3): 202-12.
25. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009; 284 (33): 21777-81.
26. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003; 22 (53): 8543-67.
27. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008; 18 (4): 157-64.
28. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91 (4): 479-89.
29. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 family reunion. Mol Cell 2010; 37 (3): 299-310.
30. Silke J, Hawkins CJ, Ekert PG, Chew J, Day CL, Pakusch M, et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3-and caspase 9-interacting sites. J Cell Biol 2002; 157 (1): 115-24.
31. Vaux DL, Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 2003; 304 (3): 499-504.
32. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8 (3): 613-21.
33. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosisinducing factor. Nature 1999; 397 (6718): 441-6.
34. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412 (6842): 95-9.
35. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000; 192 (4): 571-80.
36. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11 (9): 372-7.
37. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114 (2): 181-90.
38. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137 (3): 413-31.
39. Yu ZK, Geyer RK, Maki CG. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene 2000; 19 (51): 5892-7.
40. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 1998; 17 (2): 554-64.
41. Jeffrey PD, Gorina S, Pavletich NP. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 1995; 267 (5203): 1498-502.
42. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003; 15 (2): 164-71.
43. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187 (1): 112-26.
44. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003; 22 (56): 9030-40.
45. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408 (6810): 307-10.
46. Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009; 1787 (5): 414-20.
47. Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3 (6): 552-8.
48. Robles AI, Bemmels NA, Foraker AB, Harris CC. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 2001; 61 (18): 6660-4.
49. Schilling T, Schleithoff ES, Kairat A, Melino G, Stremmel W, Oren M, et al. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochem Biophys Res Commun 2009; 387 (2): 399-404.
50. Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13 (6): 951-61.
51. Moll UM, Wolff S, Speidel D, Deppert W. Transcriptionindependent pro-apoptotic functions of p53. Curr Opin Cell Biol 2005; 17 (6): 631-6.
52. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458 (7242): 1127-30.
53. Zuckerman V, Wolyniec K, Sionov RV, Haupt S, Haupt Y. Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol 2009; 219 (1): 3-15.
54. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 2010; 20 (1): 14-24.
55. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303 (5660): 1010-4.
56. Jiang P, Du W, Heese K, Wu M. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol 2006; 26 (23): 9071-82.
57. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005; 309 (5741): 1732-5.
58. Leu JI, George DL. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 2007; 21 (23): 3095-109.
59. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 2007; 26 (4): 923-34.
60. Saleem A, Adhihetty PJ, Hood DA. Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol Genomics 2009; 37 (1): 58-66.
61. Park JY, Wang PY, Matsumoto T, Sung HJ, Ma W, Choi JW, et al. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 2009; 105 (7): 705-12.
62. Whitman SA, Wacker MJ, Richmond SR, Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch 2005; 450 (6): 437-46.
63. Marzetti E, Wohlgemuth SE, Lees HA, Chung HY, Giovannini S, Leeuwenburgh C. Age-related activation of mitochondrial caspaseindependent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev 2008; 129 (9): 542-9.
64. Alway SE, Degens H, Krishnamurthy G, Smith CA. Potential role for Id myogenic repressors in apoptosis and attenuation of hypertrophy in muscles of aged rats. Am J Physiol Cell Physiol 2002; 283 (1): C66-76.
65. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 2009; 106 (48): 20405-10.
66. Joza N, Oudit GY, Brown D, Benit P, Kassiri Z, Vahsen N, et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 2005; 25 (23): 10261-72.
67. Dupont-Versteegden EE, Strotman BA, Gurley CM, Gaddy D, Knox M, Fluckey JD, et al. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. Am J Physiol Regul Integr Comp Physiol 2006; 291 (6): R1730-40.
68. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003; 23 (1): 15-39.
69. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8 (3): 131-6.
70. Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000; 279 (4): R1165-70.
71. Stewart CE, Newcomb PV, Holly JM. Multifaceted roles of TNFalpha in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 2004; 198 (2): 237-47.
72. MacLachlan TK, Giordano A. TRAF2 expression in differentiated muscle. J Cell Biochem 1998; 71 (4): 461-6.
73. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 1989; 83 (5): 1614-22.
74. Hoshino E, Pichard C, Greenwood CE, Kuo GC, Cameron RG, Kurian R, et al. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol 1991; 260 (1 Pt 1): E27-36.
75. Raina N, Jeejeebhoy KN. Changes in body composition and dietary intake induced by tumor necrosis factor alpha and corticosterone--individually and in combination. Am J Clin Nutr 1998; 68 (6): 1284-90.
76. Carbo N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ, Argiles JM. TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 2002; 86 (6): 1012-6.
77. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygenmediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 1998; 12 (10): 871-80.
78. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004; 59 (6): 483-7.
79. Brune B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 351 (3): 261-72.
80. Reiter CD, Teng RJ, Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 2000; 275 (42): 32460-6.
81. Drew B, Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann N Y Acad Sci 2002; 959: 66-81.
82. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997; 272 (3): 1433-6.
83. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, et al. TNFalpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005; 19 (3): 362-70.
84. Buford TW, Cooke MB, Manini TM, Leeuwenburgh C, Willoughby DS. Effects of age and sedentary lifestyle on skeletal muscle NF-kappaB signaling in men. J Gerontol A Biol Sci Med Sci 2010; 65 (5): 532-7.
85. Siu PM, Pistilli EE, Murlasits Z, Alway SE. Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. J Appl Physiol 2006; 100 (3): 907-16.
86. Siu PM, Alway SE. Id2 and p53 participate in apoptosis during unloading-induced muscle atrophy. Am J Physiol Cell Physiol 2005; 288 (5): C1058-73.
87. Chung L, Ng YC. Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle. Biochim Biophys Acta 2006; 1762 (1): 103-9.
88. Edwards MG, Anderson RM, Yuan M, Kendziorski CM, Weindruch R, Prolla TA. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 2007; 8: 80.
89. Alway SE, Siu PM. Nuclear apoptosis contributes to sarcopenia. Exerc Sport Sci Rev 2008; 36 (2): 51-7.
90. Tews DS. Apoptosis and muscle fibre loss in neuromuscular disorders. Neuromuscul Disord 2002; 12 (7-8): 613-22.
91. McClung JM, Kavazis AN, DeRuisseau KC, Falk DJ, Deering MA, Lee Y, et al. Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy. Am J Respir Crit Care Med 2007; 175 (2): 150-9.
92. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113 (1): 115-23.